Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04452474
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

Who this might be right for
COVID-19
R-Pharm
Not applicableUnknownNCT04904523
What this trial is testing

Blood Markers for Identifying & Investigating Infection With COVID19 & Sepsis in Children.

Who this might be right for
Covid19Sepsis
Cardiff University 300
Early research (Phase 1)Study completedNCT05339334
What this trial is testing

Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Who this might be right for
Healthy Participants
Pfizer 14
Not applicableStudy completedNCT04389944
What this trial is testing

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Who this might be right for
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
University Hospital, Basel, Switzerland 15
Not applicableStudy completedNCT05097677
What this trial is testing

Follow-up of Covid-19 Long Term Sequelae

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Bronchitis+15 more
Azienda Ospedaliera Universitaria Integrata Verona 7,599
Large-scale testing (Phase 3)Ended earlyNCT04389840
What this trial is testing

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Acute Lung InjurySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Jazz Pharmaceuticals 27
Early research (Phase 1)Study completedNCT05263921
What this trial is testing

Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Bioavailability
Pfizer 12
Testing effectiveness (Phase 2)UnknownNCT04268537
What this trial is testing

Immunoregulatory Therapy for 2019-nCoV

Who this might be right for
2019 nCoV, PD-1
Southeast University, China 120
Testing effectiveness (Phase 2)Ended earlyNCT04992273
What this trial is testing

COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 7
Not applicableStudy completedNCT04609774
What this trial is testing

Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019

Who this might be right for
Coronavirus Disease (COVID-19)
Hospital Italiano de Buenos Aires 8
Testing effectiveness (Phase 2)Ended earlyNCT04969991
What this trial is testing

Study of Varespladib in Patients Hospitalized With Severe COVID-19

Who this might be right for
Coronavirus Disease 2019Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Ophirex, Inc. 18
Large-scale testing (Phase 3)Looking for participantsNCT07743580
What this trial is testing

Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Who this might be right for
SARS-CoV-2
Shionogi 2,000
Early research (Phase 1)WithdrawnNCT05178654
What this trial is testing

Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants.

Who this might be right for
Healthy Participants
Pfizer
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Testing effectiveness (Phase 2)Ended earlyNCT04668209
What this trial is testing

Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus
University of Arizona 31
Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Post-approval studies (Phase 4)Study completedNCT04394117
What this trial is testing

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

Who this might be right for
Coronavirus Disease 2019COVID-19
The George Institute 787
Early research (Phase 1)Active Not RecruitingNCT07709637
What this trial is testing

Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 1
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Next Page